Supplemental Table 2. Full list of Impacts Endorsed during Patient Interviews.docx (16.44 kB)

fon-2021-0773 - Supplemental Table 2. Full list of Impacts Endorsed during Patient Interviews

dataset

posted on 19.10.2021, 15:36 by Angela Stroupe, Koichiro Akakura, Hiroji Uemura, Kikuko Miyazaki, Caroline Seo, Alyssa Uzumcu, Dianne Ledesma

Supplemental Table 2. Full list of Impacts Endorsed during Patient Interviews

History

Usage metrics

Read the peer-reviewed publication

A Qualitative Research Study in Japan Investigating Patients’ Experience with Metastatic Castration-Resistant Prostate Cancer: From Diagnosis to Decision for Ra-223 Treatment

Future Oncology

Categories

Keywords

Patient Journey Ra-223 mCRPC symptoms impacts Radiotherapy Oncology and Carcinogenesis not elsewhere classified Public Health and Health Services not elsewhere classified

Licence

CC BY-NC-ND 4.0

Exports